nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Mesenteric occlusion—Riluzole—amyotrophic lateral sclerosis	0.0827	0.18	CcSEcCtD
Acamprosate—Intentional injury—Riluzole—amyotrophic lateral sclerosis	0.0344	0.0746	CcSEcCtD
Acamprosate—Panophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0255	CcSEcCtD
Acamprosate—GRIN2C—nerve—amyotrophic lateral sclerosis	0.0114	0.0511	CbGeAlD
Acamprosate—GRM5—hindbrain—amyotrophic lateral sclerosis	0.0112	0.0502	CbGeAlD
Acamprosate—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.00948	0.0206	CcSEcCtD
Acamprosate—GRIN2B—nerve—amyotrophic lateral sclerosis	0.00901	0.0404	CbGeAlD
Acamprosate—GRIN2C—hindbrain—amyotrophic lateral sclerosis	0.00854	0.0383	CbGeAlD
Acamprosate—GRIN2D—hindbrain—amyotrophic lateral sclerosis	0.00794	0.0356	CbGeAlD
Acamprosate—GRIN2A—nerve—amyotrophic lateral sclerosis	0.00788	0.0353	CbGeAlD
Acamprosate—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00724	0.0157	CcSEcCtD
Acamprosate—GRIN1—hindbrain—amyotrophic lateral sclerosis	0.00708	0.0317	CbGeAlD
Acamprosate—GRIN2B—hindbrain—amyotrophic lateral sclerosis	0.00675	0.0302	CbGeAlD
Acamprosate—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00674	0.0146	CcSEcCtD
Acamprosate—GRM5—brainstem—amyotrophic lateral sclerosis	0.00643	0.0288	CbGeAlD
Acamprosate—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00611	0.0133	CcSEcCtD
Acamprosate—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00601	0.0131	CcSEcCtD
Acamprosate—GRIN2A—hindbrain—amyotrophic lateral sclerosis	0.0059	0.0264	CbGeAlD
Acamprosate—SLC36A1—hindbrain—amyotrophic lateral sclerosis	0.00586	0.0263	CbGeAlD
Acamprosate—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00517	0.0112	CcSEcCtD
Acamprosate—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00505	0.011	CcSEcCtD
Acamprosate—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00505	0.011	CcSEcCtD
Acamprosate—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00499	0.0108	CcSEcCtD
Acamprosate—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00493	0.0107	CcSEcCtD
Acamprosate—GRIN2C—brainstem—amyotrophic lateral sclerosis	0.0049	0.0219	CbGeAlD
Acamprosate—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00476	0.0103	CcSEcCtD
Acamprosate—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0102	CcSEcCtD
Acamprosate—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00989	CcSEcCtD
Acamprosate—GRIN2D—brainstem—amyotrophic lateral sclerosis	0.00455	0.0204	CbGeAlD
Acamprosate—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00949	CcSEcCtD
Acamprosate—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00912	CcSEcCtD
Acamprosate—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00895	CcSEcCtD
Acamprosate—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00886	CcSEcCtD
Acamprosate—GRIN1—brainstem—amyotrophic lateral sclerosis	0.00406	0.0182	CbGeAlD
Acamprosate—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0087	CcSEcCtD
Acamprosate—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0087	CcSEcCtD
Acamprosate—GRM5—spinal cord—amyotrophic lateral sclerosis	0.004	0.0179	CbGeAlD
Acamprosate—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00862	CcSEcCtD
Acamprosate—Mania—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00855	CcSEcCtD
Acamprosate—GRIN2B—brainstem—amyotrophic lateral sclerosis	0.00387	0.0173	CbGeAlD
Acamprosate—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00805	CcSEcCtD
Acamprosate—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00786	CcSEcCtD
Acamprosate—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00773	CcSEcCtD
Acamprosate—GRIN2C—medulla oblongata—amyotrophic lateral sclerosis	0.00341	0.0153	CbGeAlD
Acamprosate—GRIN2A—brainstem—amyotrophic lateral sclerosis	0.00338	0.0152	CbGeAlD
Acamprosate—GRM5—nervous system—amyotrophic lateral sclerosis	0.00337	0.0151	CbGeAlD
Acamprosate—SLC36A1—brainstem—amyotrophic lateral sclerosis	0.00336	0.0151	CbGeAlD
Acamprosate—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00328	0.0147	CbGeAlD
Acamprosate—GRM5—central nervous system—amyotrophic lateral sclerosis	0.00324	0.0145	CbGeAlD
Acamprosate—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00703	CcSEcCtD
Acamprosate—GRIN2D—medulla oblongata—amyotrophic lateral sclerosis	0.00317	0.0142	CbGeAlD
Acamprosate—GRM5—cerebellum—amyotrophic lateral sclerosis	0.00317	0.0142	CbGeAlD
Acamprosate—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00679	CcSEcCtD
Acamprosate—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00679	CcSEcCtD
Acamprosate—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00309	0.0067	CcSEcCtD
Acamprosate—Gout—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00666	CcSEcCtD
Acamprosate—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00629	CcSEcCtD
Acamprosate—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00622	CcSEcCtD
Acamprosate—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00622	CcSEcCtD
Acamprosate—GRIN2D—spinal cord—amyotrophic lateral sclerosis	0.00283	0.0127	CbGeAlD
Acamprosate—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00614	CcSEcCtD
Acamprosate—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00607	CcSEcCtD
Acamprosate—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00276	0.006	CcSEcCtD
Acamprosate—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00584	CcSEcCtD
Acamprosate—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00571	CcSEcCtD
Acamprosate—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00562	CcSEcCtD
Acamprosate—GRM5—brain—amyotrophic lateral sclerosis	0.00257	0.0115	CbGeAlD
Acamprosate—GRIN2C—nervous system—amyotrophic lateral sclerosis	0.00256	0.0115	CbGeAlD
Acamprosate—GRIN1—spinal cord—amyotrophic lateral sclerosis	0.00252	0.0113	CbGeAlD
Acamprosate—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00539	CcSEcCtD
Acamprosate—GRIN2C—central nervous system—amyotrophic lateral sclerosis	0.00247	0.0111	CbGeAlD
Acamprosate—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00529	CcSEcCtD
Acamprosate—GRIN2C—cerebellum—amyotrophic lateral sclerosis	0.00241	0.0108	CbGeAlD
Acamprosate—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00524	CcSEcCtD
Acamprosate—GRIN2B—spinal cord—amyotrophic lateral sclerosis	0.00241	0.0108	CbGeAlD
Acamprosate—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00519	CcSEcCtD
Acamprosate—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00519	CcSEcCtD
Acamprosate—GRIN2D—nervous system—amyotrophic lateral sclerosis	0.00238	0.0107	CbGeAlD
Acamprosate—GRIN2A—medulla oblongata—amyotrophic lateral sclerosis	0.00236	0.0106	CbGeAlD
Acamprosate—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00504	CcSEcCtD
Acamprosate—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00502	CcSEcCtD
Acamprosate—GRIN2D—central nervous system—amyotrophic lateral sclerosis	0.0023	0.0103	CbGeAlD
Acamprosate—Injury—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00491	CcSEcCtD
Acamprosate—GRIN2D—cerebellum—amyotrophic lateral sclerosis	0.00224	0.0101	CbGeAlD
Acamprosate—GRIN3A—nervous system—amyotrophic lateral sclerosis	0.00224	0.01	CbGeAlD
Acamprosate—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00487	CcSEcCtD
Acamprosate—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0048	CcSEcCtD
Acamprosate—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0048	CcSEcCtD
Acamprosate—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00478	CcSEcCtD
Acamprosate—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00474	CcSEcCtD
Acamprosate—GRIN3A—central nervous system—amyotrophic lateral sclerosis	0.00216	0.00967	CbGeAlD
Acamprosate—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00464	CcSEcCtD
Acamprosate—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00462	CcSEcCtD
Acamprosate—GRIN1—nervous system—amyotrophic lateral sclerosis	0.00213	0.00952	CbGeAlD
Acamprosate—GRIN2A—spinal cord—amyotrophic lateral sclerosis	0.0021	0.00942	CbGeAlD
Acamprosate—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00453	CcSEcCtD
Acamprosate—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00451	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00451	CcSEcCtD
Acamprosate—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00448	CcSEcCtD
Acamprosate—GRIN1—central nervous system—amyotrophic lateral sclerosis	0.00205	0.00917	CbGeAlD
Acamprosate—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00444	CcSEcCtD
Acamprosate—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00441	CcSEcCtD
Acamprosate—GRIN2B—nervous system—amyotrophic lateral sclerosis	0.00203	0.00908	CbGeAlD
Acamprosate—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00436	CcSEcCtD
Acamprosate—GRIN1—cerebellum—amyotrophic lateral sclerosis	0.002	0.00896	CbGeAlD
Acamprosate—GRIN2C—brain—amyotrophic lateral sclerosis	0.00196	0.00878	CbGeAlD
Acamprosate—GRIN2B—central nervous system—amyotrophic lateral sclerosis	0.00195	0.00875	CbGeAlD
Acamprosate—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00417	CcSEcCtD
Acamprosate—GRIN2B—cerebellum—amyotrophic lateral sclerosis	0.00191	0.00855	CbGeAlD
Acamprosate—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00412	CcSEcCtD
Acamprosate—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00188	0.00843	CbGeAlD
Acamprosate—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00408	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00406	CcSEcCtD
Acamprosate—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00399	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00398	CcSEcCtD
Acamprosate—GRIN2D—brain—amyotrophic lateral sclerosis	0.00182	0.00817	CbGeAlD
Acamprosate—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00393	CcSEcCtD
Acamprosate—Asthma—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0039	CcSEcCtD
Acamprosate—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0039	CcSEcCtD
Acamprosate—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0039	CcSEcCtD
Acamprosate—GRIN2A—nervous system—amyotrophic lateral sclerosis	0.00177	0.00794	CbGeAlD
Acamprosate—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00382	CcSEcCtD
Acamprosate—SLC36A1—nervous system—amyotrophic lateral sclerosis	0.00176	0.00789	CbGeAlD
Acamprosate—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0038	CcSEcCtD
Acamprosate—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00375	CcSEcCtD
Acamprosate—GRIN3A—brain—amyotrophic lateral sclerosis	0.00171	0.00768	CbGeAlD
Acamprosate—GRIN2A—central nervous system—amyotrophic lateral sclerosis	0.00171	0.00764	CbGeAlD
Acamprosate—SLC36A1—central nervous system—amyotrophic lateral sclerosis	0.0017	0.0076	CbGeAlD
Acamprosate—GRIN2A—cerebellum—amyotrophic lateral sclerosis	0.00167	0.00747	CbGeAlD
Acamprosate—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0036	CcSEcCtD
Acamprosate—SLC36A1—cerebellum—amyotrophic lateral sclerosis	0.00166	0.00742	CbGeAlD
Acamprosate—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00359	CcSEcCtD
Acamprosate—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00356	CcSEcCtD
Acamprosate—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00355	CcSEcCtD
Acamprosate—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00353	CcSEcCtD
Acamprosate—GRIN1—brain—amyotrophic lateral sclerosis	0.00162	0.00728	CbGeAlD
Acamprosate—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0035	CcSEcCtD
Acamprosate—Depression—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00347	CcSEcCtD
Acamprosate—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00343	CcSEcCtD
Acamprosate—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00341	CcSEcCtD
Acamprosate—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00339	CcSEcCtD
Acamprosate—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00338	CcSEcCtD
Acamprosate—GRIN2B—brain—amyotrophic lateral sclerosis	0.00155	0.00694	CbGeAlD
Acamprosate—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00333	CcSEcCtD
Acamprosate—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00332	CcSEcCtD
Acamprosate—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00328	CcSEcCtD
Acamprosate—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00149	0.00666	CbGeAlD
Acamprosate—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00314	CcSEcCtD
Acamprosate—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00313	CcSEcCtD
Acamprosate—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00312	CcSEcCtD
Acamprosate—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00312	CcSEcCtD
Acamprosate—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00311	CcSEcCtD
Acamprosate—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00311	CcSEcCtD
Acamprosate—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0031	CcSEcCtD
Acamprosate—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00308	CcSEcCtD
Acamprosate—GRIN2A—brain—amyotrophic lateral sclerosis	0.00135	0.00607	CbGeAlD
Acamprosate—SLC36A1—brain—amyotrophic lateral sclerosis	0.00135	0.00603	CbGeAlD
Acamprosate—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00132	0.00594	CbGeAlD
Acamprosate—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00131	0.00588	CbGeAlD
Acamprosate—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00282	CcSEcCtD
Acamprosate—Chills—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0028	CcSEcCtD
Acamprosate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00276	CcSEcCtD
Acamprosate—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00274	CcSEcCtD
Acamprosate—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00272	CcSEcCtD
Acamprosate—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00268	CcSEcCtD
Acamprosate—Tension—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00267	CcSEcCtD
Acamprosate—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00266	CcSEcCtD
Acamprosate—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00264	CcSEcCtD
Acamprosate—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00263	CcSEcCtD
Acamprosate—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00261	CcSEcCtD
Acamprosate—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00255	CcSEcCtD
Acamprosate—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00117	0.00524	CbGeAlD
Acamprosate—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00252	CcSEcCtD
Acamprosate—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00251	CcSEcCtD
Acamprosate—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0025	CcSEcCtD
Acamprosate—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00248	CcSEcCtD
Acamprosate—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00114	0.00511	CbGeAlD
Acamprosate—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00245	CcSEcCtD
Acamprosate—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00244	CcSEcCtD
Acamprosate—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00244	CcSEcCtD
Acamprosate—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00243	CcSEcCtD
Acamprosate—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00112	0.005	CbGeAlD
Acamprosate—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0024	CcSEcCtD
Acamprosate—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00239	CcSEcCtD
Acamprosate—Cough—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00237	CcSEcCtD
Acamprosate—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00235	CcSEcCtD
Acamprosate—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00235	CcSEcCtD
Acamprosate—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00107	0.00482	CbGeAlD
Acamprosate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00231	CcSEcCtD
Acamprosate—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00231	CcSEcCtD
Acamprosate—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00231	CcSEcCtD
Acamprosate—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00231	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0023	CcSEcCtD
Acamprosate—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00229	CcSEcCtD
Acamprosate—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00105	0.00471	CbGeAlD
Acamprosate—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00226	CcSEcCtD
Acamprosate—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00224	CcSEcCtD
Acamprosate—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00222	CcSEcCtD
Acamprosate—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00102	0.00456	CbGeAlD
Acamprosate—Infection—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0022	CcSEcCtD
Acamprosate—Shock—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00218	CcSEcCtD
Acamprosate—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.001	0.00217	CcSEcCtD
Acamprosate—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000997	0.00216	CcSEcCtD
Acamprosate—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00215	CcSEcCtD
Acamprosate—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000988	0.00214	CcSEcCtD
Acamprosate—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000986	0.00442	CbGeAlD
Acamprosate—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000974	0.00211	CcSEcCtD
Acamprosate—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000955	0.00207	CcSEcCtD
Acamprosate—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.000949	0.00425	CbGeAlD
Acamprosate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000931	0.00202	CcSEcCtD
Acamprosate—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.000928	0.00416	CbGeAlD
Acamprosate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000924	0.00201	CcSEcCtD
Acamprosate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00199	CcSEcCtD
Acamprosate—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000911	0.00198	CcSEcCtD
Acamprosate—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000908	0.00197	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0009	0.00285	CbGpPWpGaD
Acamprosate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00195	CcSEcCtD
Acamprosate—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000888	0.00193	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000887	0.0028	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000882	0.00191	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.000878	0.00278	CbGpPWpGaD
Acamprosate—Pain—Riluzole—amyotrophic lateral sclerosis	0.000874	0.0019	CcSEcCtD
Acamprosate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000874	0.0019	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000869	0.00275	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.000865	0.00274	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000864	0.00273	CbGpPWpGaD
Acamprosate—GABRB3—nervous system—amyotrophic lateral sclerosis	0.000857	0.00384	CbGeAlD
Acamprosate—GABRG2—brain—amyotrophic lateral sclerosis	0.000853	0.00382	CbGeAlD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000842	0.00266	CbGpPWpGaD
Acamprosate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000842	0.00183	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000837	0.00265	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000835	0.00181	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000835	0.00264	CbGpPWpGaD
Acamprosate—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.000825	0.0037	CbGeAlD
Acamprosate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000812	0.00176	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000808	0.00256	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000808	0.00255	CbGpPWpGaD
Acamprosate—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000808	0.00175	CcSEcCtD
Acamprosate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000808	0.00175	CcSEcCtD
Acamprosate—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.000807	0.00361	CbGeAlD
Acamprosate—GRIN1—Mecp2 and Associated Rett Syndrome—BDNF—amyotrophic lateral sclerosis	0.000798	0.00252	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000797	0.00252	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000795	0.00251	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.00078	0.00247	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000777	0.00246	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.00076	0.0024	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000759	0.0024	CbGpPWpGaD
Acamprosate—GABRA1—brain—amyotrophic lateral sclerosis	0.000754	0.00338	CbGeAlD
Acamprosate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000753	0.00163	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000751	0.00237	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000747	0.00236	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000745	0.00236	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000739	0.00234	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000739	0.00234	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000739	0.00234	CbGpPWpGaD
Acamprosate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000733	0.00159	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000728	0.0023	CbGpPWpGaD
Acamprosate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000723	0.00157	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00071	0.00225	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000704	0.00223	CbGpPWpGaD
Acamprosate—GABRB3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000702	0.00222	CbGpPWpGaD
Acamprosate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000699	0.00152	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000695	0.0022	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00069	0.00218	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000689	0.00218	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000687	0.00217	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000687	0.00217	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000687	0.00217	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000687	0.00217	CbGpPWpGaD
Acamprosate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00147	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000666	0.00211	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000664	0.0021	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000659	0.00208	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000659	0.00208	CbGpPWpGaD
Acamprosate—GABRB3—brain—amyotrophic lateral sclerosis	0.000655	0.00294	CbGeAlD
Acamprosate—GRIN1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00065	0.00205	CbGpPWpGaD
Acamprosate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00141	CcSEcCtD
Acamprosate—Rash—Riluzole—amyotrophic lateral sclerosis	0.000644	0.0014	CcSEcCtD
Acamprosate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000644	0.0014	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000641	0.00203	CbGpPWpGaD
Acamprosate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00064	0.00139	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000635	0.00201	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000633	0.002	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000633	0.002	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000632	0.002	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000619	0.00196	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000619	0.00196	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000615	0.00195	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000613	0.00194	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000609	0.00193	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000607	0.00192	CbGpPWpGaD
Acamprosate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00132	CcSEcCtD
Acamprosate—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000602	0.0019	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000601	0.0019	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000601	0.0019	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000601	0.0019	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0006	0.0019	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000587	0.00186	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000584	0.00185	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000579	0.00183	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000571	0.0018	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00057	0.0018	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000566	0.00179	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000566	0.00179	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000566	0.00179	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000564	0.00178	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000564	0.00178	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000564	0.00178	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00056	0.00177	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000557	0.00176	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000543	0.00172	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00053	0.00167	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000528	0.00167	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000527	0.00167	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000527	0.00167	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000527	0.00167	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000526	0.00166	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000517	0.00163	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000516	0.00163	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.000514	0.00163	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000509	0.00161	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000505	0.0016	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000503	0.00159	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000498	0.00157	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000492	0.00156	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000492	0.00156	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000489	0.00155	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000485	0.00153	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000482	0.00152	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00048	0.00152	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00048	0.00152	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000469	0.00148	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000465	0.00147	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000465	0.00147	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000459	0.00145	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000456	0.00144	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000452	0.00143	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000448	0.00142	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000444	0.0014	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00044	0.00139	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000439	0.00139	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000432	0.00137	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000432	0.00137	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000432	0.00137	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000429	0.00136	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000429	0.00136	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000428	0.00135	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000424	0.00134	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000421	0.00133	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000421	0.00133	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00041	0.0013	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000406	0.00128	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000402	0.00127	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000399	0.00126	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000396	0.00125	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000395	0.00125	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000388	0.00123	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000388	0.00123	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000385	0.00122	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000382	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000381	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000377	0.00119	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000377	0.00119	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000375	0.00119	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000373	0.00118	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000372	0.00118	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000368	0.00116	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000368	0.00116	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000368	0.00116	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000367	0.00116	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000361	0.00114	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000361	0.00114	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000349	0.0011	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000348	0.0011	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000343	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00034	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00034	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00034	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000339	0.00107	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000336	0.00106	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000331	0.00105	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000328	0.00104	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000328	0.00104	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000328	0.00104	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000325	0.00103	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000325	0.00103	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000323	0.00102	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000322	0.00102	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000322	0.00102	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000319	0.00101	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000319	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000316	0.000998	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000311	0.000983	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000307	0.00097	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000303	0.000958	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0003	0.000948	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000298	0.000941	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000293	0.000926	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00029	0.000918	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000289	0.000915	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000287	0.000909	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000284	0.000899	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000282	0.000891	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000279	0.000882	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000279	0.000882	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000272	0.00086	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000268	0.000849	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000268	0.000846	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000268	0.000846	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000265	0.000839	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000263	0.000831	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000261	0.000825	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00026	0.000823	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000258	0.000815	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000251	0.000794	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000249	0.000787	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000249	0.000787	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000248	0.000786	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000246	0.000778	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000244	0.000773	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000244	0.000773	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000244	0.000772	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00024	0.000758	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000239	0.000757	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000231	0.000732	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00023	0.000727	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000222	0.000701	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	0.00022	0.000696	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000219	0.000694	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000219	0.000691	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000218	0.000689	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	0.000214	0.000678	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000214	0.000675	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000214	0.000675	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000212	0.000672	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00021	0.000663	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000209	0.000661	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	0.000198	0.000625	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000197	0.000622	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000194	0.000614	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	0.000193	0.000609	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00019	0.000602	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000189	0.000596	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000186	0.00059	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000183	0.00058	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000176	0.000556	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000172	0.000542	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000167	0.000529	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000165	0.000523	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000161	0.00051	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000157	0.000498	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000156	0.000493	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000155	0.000491	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000155	0.000489	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000152	0.00048	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000138	0.000436	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000135	0.000427	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000134	0.000423	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000134	0.000423	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000132	0.000417	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000131	0.000415	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000131	0.000415	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000128	0.000405	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000124	0.000394	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00012	0.00038	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000119	0.000377	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000117	0.00037	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000115	0.000363	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000115	0.000363	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000114	0.000362	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000109	0.000345	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000102	0.000324	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.8e-05	0.00031	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.21e-05	0.000291	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	8.79e-05	0.000278	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—amyotrophic lateral sclerosis	8.17e-05	0.000259	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.14e-05	0.000257	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—amyotrophic lateral sclerosis	7.97e-05	0.000252	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.58e-05	0.00024	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	7.46e-05	0.000236	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—amyotrophic lateral sclerosis	7.34e-05	0.000232	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—amyotrophic lateral sclerosis	7.16e-05	0.000226	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.26e-05	0.000198	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	5.83e-05	0.000184	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	5.69e-05	0.00018	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	5.24e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	5.11e-05	0.000161	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.82e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.55e-05	0.000144	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.09e-05	0.000129	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.09e-05	9.77e-05	CbGpPWpGaD
